Vtv Therapeutics INC Schedule 13G passive stakes

Several entities affiliated with Millennium Management have reported beneficial ownership of vTv Therapeutics Inc. Class A Common Stock, collectively holding approximately 6.9% of the outstanding shares.

Millennium Management and affiliated entities have filed a Schedule 13G reporting a 5.7% beneficial ownership stake in vTv Therapeutics Inc.

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has reported a 5.0% beneficial ownership stake in vTv Therapeutics Inc.

Raymond Debbane and affiliated entities, including Invus Public Equities, report a combined beneficial ownership of 9.4% in vTv Therapeutics Inc. Class A Common Stock.

Trails Edge Capital Partners, LP and affiliates have reported a 9.9% passive ownership stake in vTv Therapeutics Inc. common stock.

Investment entities linked to Raymond Debbane have reported a 9.99% beneficial ownership in vTv Therapeutics Inc., including common stock and warrants.